title: [Capabilities of pharmacological correction with Reamberin the cerebrovascular disorders with ENT diseases of the elderly patients].
abstract: Endointoxication's syndrome and manifestations of immune deficiency observed among elderly patients with acute exacerbations of ENT diseases and concomitant cerebrovascular pathology. Reamberin in pathogenetic therapy arrests manifestations of intoxication and optimizes immunobiological homeostasis.
authors: N A
authors: NA
authors: Peresadin
authors: T V
authors: TV
authors: D'iachenko
authors: A Iu
authors: AIu
authors: Kasparevich
authors: M D
authors: MD
authors: Krivosheeva
mesh_terms: D000368:Aged; D002908:Chronic Disease; D016903:Drug Monitoring; D019446:Endotoxemia / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D020925:Hypoxia-Ischemia, Brain / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D007155:Immunologic Factors / Q000008:administration & dosage; D007262:Infusions, Intravenous; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018696:Neuroprotective Agents / Q000008:administration & dosage; D010038:Otorhinolaryngologic Diseases / Q000145:classification / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D062072:Patient Acuity; D013386:Succinates / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors; D018696:Neuroprotective Agents; C549374:Reamberin; D013386:Succinates; D008536:Meglumine